A Study of Cizutamig in Patients With Immunoglobulin A Nephropathy

NCT07135219 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ENROLLING_BY_INVITATION

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Immunoglobulin A Nephropathy (IgAN)

Interventions

DRUG: Biological: cizutamig

Sponsor

Peking University First Hospital